With its stock down 23% over the past month, it is easy to disregard Semler Scientific (NASDAQ:SMLR). But if you ...

Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) in Q4 CY2024, but sales rose 10.6% year on year to $172 ...

We recently compiled a list of the Jim Cramer Discusses These 11 Stocks & Finds Few Reasons To Sell. In this article, we are ...

Apple's ecosystem, premium positioning, and focus on privacy are driving its dominance in health tech, poised to disrupt ...

Enovix's high-performance batteries and Fortune 50 partnership could shape its future. ENVX stock's future hinges on hitting ...